Explore
Validate
Learn
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [10]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 17335-1-AP - Provider product page
- Provider
- Proteintech Group
- Product name
- CD8a antibody
- Antibody type
- Polyclonal
- Description
- CD8a antibody (Cat. #17335-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: IHC,ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Oxidative Stress-Responsive Apoptosis Inducing Protein (ORAIP) Plays a Critical Role in Dextran Sulfate Sodium-Induced Murine Model of Ulcerative Colitis.
Influence of PD-1/PD-L1 on immune microenvironment in oral leukoplakia and oral squamous cell carcinoma.
Integrated DNA and RNA sequencing reveals early drivers involved in metastasis of gastric cancer.
Changes in Tumor-Infiltrating Lymphocytes and Vascular Normalization in Breast Cancer Patients After Neoadjuvant Chemotherapy and Their Correlations With DFS.
Survival analysis with regard to PD-L1 and CD155 expression in human small cell lung cancer and a comparison with associated receptors.
α2,6-Sialylation promotes immune escape in hepatocarcinoma cells by regulating T cell functions and CD147/MMP signaling.
Clinical significance of programmed death 1/programmed death ligand 1 pathway in gastric neuroendocrine carcinomas.
Detection of EBV and HHV6 in the Brain Tissue of Patients with Rasmussen's Encephalitis.
PD-1 axis expression in musculoskeletal tumors and antitumor effect of nivolumab in osteosarcoma model of humanized mouse.
Inhibiting the CD8(+) T cell infiltration in the tumor microenvironment after radiotherapy is an important mechanism of radioresistance.
Nakajima A, Shibuya T, Yao T, Fujimura T, Murayama K, Okumura K, Nagahara A, Seko Y
Medicina (Kaunas, Lithuania) 2024 Mar 26;60(4)
Medicina (Kaunas, Lithuania) 2024 Mar 26;60(4)
Influence of PD-1/PD-L1 on immune microenvironment in oral leukoplakia and oral squamous cell carcinoma.
Xu SB, Wang MY, Shi XZ, Wang Q, Yu M, Zhang W, Xu XH, Liu LK
Oral diseases 2023 Nov;29(8):3268-3277
Oral diseases 2023 Nov;29(8):3268-3277
Integrated DNA and RNA sequencing reveals early drivers involved in metastasis of gastric cancer.
Zhang J, Liu F, Yang Y, Yu N, Weng X, Yang Y, Gong Z, Huang S, Gan L, Sun S, Zhang X, Gong Y, Liu Y, Guo W
Cell death & disease 2022 Apr 21;13(4):392
Cell death & disease 2022 Apr 21;13(4):392
Changes in Tumor-Infiltrating Lymphocytes and Vascular Normalization in Breast Cancer Patients After Neoadjuvant Chemotherapy and Their Correlations With DFS.
Wang Q, Xiang Q, Yu L, Hu T, Chen Y, Wang J, Nie X, Cheng J
Frontiers in oncology 2019;9:1545
Frontiers in oncology 2019;9:1545
Survival analysis with regard to PD-L1 and CD155 expression in human small cell lung cancer and a comparison with associated receptors.
Xu Y, Cui G, Jiang Z, Li N, Zhang X
Oncology letters 2019 Mar;17(3):2960-2968
Oncology letters 2019 Mar;17(3):2960-2968
α2,6-Sialylation promotes immune escape in hepatocarcinoma cells by regulating T cell functions and CD147/MMP signaling.
Wang L, Li S, Yu X, Han Y, Wu Y, Wang S, Chen X, Zhang J, Wang S
Journal of physiology and biochemistry 2019 Jun;75(2):199-207
Journal of physiology and biochemistry 2019 Jun;75(2):199-207
Clinical significance of programmed death 1/programmed death ligand 1 pathway in gastric neuroendocrine carcinomas.
Yang MW, Fu XL, Jiang YS, Chen XJ, Tao LY, Yang JY, Huo YM, Liu W, Zhang JF, Liu PF, Liu Q, Hua R, Zhang ZG, Sun YW, Liu DJ
World journal of gastroenterology 2019 Apr 14;25(14):1684-1696
World journal of gastroenterology 2019 Apr 14;25(14):1684-1696
Detection of EBV and HHV6 in the Brain Tissue of Patients with Rasmussen's Encephalitis.
Liu D, Wang X, Wang Y, Wang P, Fan D, Chen S, Guan Y, Li T, An J, Luan G
Virologica Sinica 2018 Oct;33(5):402-409
Virologica Sinica 2018 Oct;33(5):402-409
PD-1 axis expression in musculoskeletal tumors and antitumor effect of nivolumab in osteosarcoma model of humanized mouse.
Zheng B, Ren T, Huang Y, Sun K, Wang S, Bao X, Liu K, Guo W
Journal of hematology & oncology 2018 Feb 6;11(1):16
Journal of hematology & oncology 2018 Feb 6;11(1):16
Inhibiting the CD8(+) T cell infiltration in the tumor microenvironment after radiotherapy is an important mechanism of radioresistance.
Chen HY, Xu L, Li LF, Liu XX, Gao JX, Bai YR
Scientific reports 2018 Aug 9;8(1):11934
Scientific reports 2018 Aug 9;8(1):11934
No comments: Submit comment
No validations: Submit validation data